An open‐label, dose‐escalation study to assess the safety and efficacy of IL‐22 agonist F‐652 in patients with alcohol‐associated hepatitis

JP Arab, TS Sehrawat, DA Simonetto, VK Verma… - …, 2020 - Wiley Online Library
Background and Aims Interleukin‐22 has beneficial effects on inflammation and impaired
hepatic regeneration that characterize alcohol‐associated hepatitis (AH). F‐652 is a …
被引用次数：131 相关文章
[HTML] nih.gov

[HTML][HTML] AN OPEN LABEL, DOSE ESCALATION STUDY TO ASSESS THE SAFETY AND EFFICACY OF IL-22 AGONIST F-652 IN PATIENTS WITH ALCOHOLIC …

JP Arab, TS Sehrawat, DA Simonetto… - Hepatology …, 2020 - ncbi.nlm.nih.gov
Background: Interleukin-22 (IL-22) has beneficial effects on inflammation and impaired
hepatic regeneration, that characterize AH. F-652 is a recombinant fusion protein of human …

An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis

JP Arab, TS Sehrawat, DA Simonetto… - Hepatology …, 2020 - pubmed.ncbi.nlm.nih.gov
Background and aims Interleukin-22 has beneficial effects on inflammation and impaired
hepatic regeneration that characterize alcohol-associated hepatitis (AH). F-652 is a …

[引用][C] An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis

JP Arab, TS Sehrawat, DA Simonetto… - Hepatology (Baltimore …, 2020 - elibrary.ru

An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis

JP Arab, TS Sehrawat, DA Simonetto… - …, 2020 - mayoclinic.elsevierpure.com
Abstract Background and Aims: Interleukin-22 has beneficial effects on inflammation and
impaired hepatic regeneration that characterize alcohol-associated hepatitis (AH). F-652 is a …

An Open‐Label, Dose‐Escalation Study to Assess the Safety and Efficacy of IL‐22 Agonist F‐652 in Patients With Alcohol‐associated Hepatitis

JP Arab, TS Sehrawat, DA Simonetto, VK Verma… - Hepatology, 2020 - journals.lww.com
Conclusions F‐652 is safe in doses up to 45 μg/kg and associated with a high rate of
improvement as determined by Lille and MELD scores, reductions in markers of …

An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis.

JP Arab, TS Sehrawat, DA Simonetto… - Hepatology …, 2020 - europepmc.org
Conclusions F-652 is safe in doses up to 45 μg/kg and associated with a high rate of
improvement as determined by Lille and MELD scores, reductions in markers of …
[PDF] iupui.edu

[PDF][PDF] An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis

JP Arab, TS Sehrawat, DA Simonetto, VK Verma… - 2020 - scholarworks.iupui.edu
Background and aims: Interleukin-22 has beneficial effects on inflammation and impaired
hepatic regeneration that characterize alcohol-associated hepatitis (AH). F-652 is a …
[PDF] iupui.edu

[PDF][PDF] AN OPEN LABEL, DOSE ESCALATION STUDY TO ASSESS THE SAFETY AND EFFICACY OF IL-22 AGONIST F-652 IN PATIENTS WITH ALCOHOLIC …

JP Arab, TS Sehrawat, DA Simonetto… - …, 2020 - scholarworks.iupui.edu
AN OPEN LABEL, DOSE ESCALATION STUDY TO ASSESS THE SAFETY AND EFFICACY OF
IL-22 AGONIST F-652 IN PATIENTS WITH ALCOHOLIC HEPATIT Page 1 AN OPEN LABEL …